UK faces medicine shortages after no deal: leaked govt report

A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

UK experimental use exemptions: Part 2—the Bolar exemption

22 July 2021 In the second of a four-part series, Sophie Topham of Marks & Clerk explains the rules around the exemption for studies, tests, and trials required for generic and biosimilar medicines.

Big Pharma

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

16 August 2019 Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Big Pharma

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More on this story

Generics

UK experimental use exemptions: Part 2—the Bolar exemption

22 July 2021 In the second of a four-part series, Sophie Topham of Marks & Clerk explains the rules around the exemption for studies, tests, and trials required for generic and biosimilar medicines.

Big Pharma

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

16 August 2019 Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Big Pharma

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

More on this story

Generics

UK experimental use exemptions: Part 2—the Bolar exemption

22 July 2021 In the second of a four-part series, Sophie Topham of Marks & Clerk explains the rules around the exemption for studies, tests, and trials required for generic and biosimilar medicines.

Big Pharma

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

16 August 2019 Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Big Pharma

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA